Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Eating a high-glycemic diet may worsen acne by increasing certain protein levels and expressions in the skin.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Menopause affects hair and skin; more research needed for treatment.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Women with PCOS have more emotional and body image issues than healthy women.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.